A new retrovirus consisting of the v-myc oncogene sequences of avian MC29 virus inserted into the genome of Moloney murine leukemia virus (M-MuLV) was generated. This was accomplished by constructing a recombinant DNA clone containing the desired organization, introducing the recombinant DNA into mouse NIH 3T3 cells, and superinfecting the cells with replication-competent M-MuLV. The construction was designed so that an M-MuLV gag-myc fusion protein would be produced. The resulting virus, M-MuLV(myc), morphologically transformed uninfected NIH 3T3 cells. Stocks of M-MuLV(myc)-M-MuLV were infected into secondary mouse embryo cultures. M-MuLV(myc) induced striking growth and proliferation of hematopoietic cells. These cells were of the myeloid lineage by morphology, phagocytic properties, and surface staining with Mac-1 and Mac-2 monoclonal antibodies. They resembled mature macrophages, although they displayed minor properties of immaturity. The myeloid cells were transformed in comparison with uninfected myeloid cells since they were less adherent and had unlimited proliferative capacity and reduced growth factor requirements. The transformed myeloid cells with proliferative potential were actually myeloid progenitors which apparently underwent terminal differentiation to macrophages. It was possible to derive a permanent line of factor-independent macrophages from M-MuLV(myc)-transformed myeloid cells. M-MuLV(myc) also immortalized and morphologically transformed mouse embryo fibroblasts. These in vitro properties closely resembled the biological activity of MC29 virus in avian cells and suggested that the nature of the v-myc oncogene was an important determinant in transformation specificity. Neonatal NIH Swiss mice inoculated intraperitoneally with M-MuLV(myc)-M-MuLV only developed lymphoblastic lymphoma characteristic of the M-MuLV helper alone, and no acute fibrosarcomas or myeloid tumors resulted. In light of the strong myeloid transformation observed in vitro, the absence of acute in vivo myeloid disease was noteworthy. Interestingly, when a derivative of M-MuLV(myc) carried by a nonpathogenic amphotropic MuLV helper was inoculated, T lymphomas developed with long latency. Molecular hybridization confirmed that these tumors contained M-MuLV(myc).
Several possible factors could influence the disease specificity of an acute transforming retrovirus. (i) The nature of the oncogene could determine disease specificity; (ii) viral protein attached to the oncogene protein could be important (39) ; or (iii) retroviral regulatory sequences (particularly in the long terminal repeat ([LTR]) could be important (49) . In addition, more than one of these factors could interact for a given retrovirus.
To investigate the molecular mechanisms of disease specificity, we have generated new transforming retroviruses by recombinant DNA techniques by inserting well-characterized oncogenes of avian acute transforming viruses into the * Corresponding author.
genome of Moloney murine leukemia virus (M-MuLV). This system offers several advantages. (i) Several avian retroviral oncogenes have been extremely well characterized and studied, and the viruses have been molecularly cloned and sequenced; (ii) M-MuLV, which predominantly causes Tcell lymphomas (42) , has also been molecularly cloned and sequenced (2, 46); and (iii) characterization and culture of mouse hematopoietic cells is well developed (8, 10, 17, 34) .
In previous experiments, we generated an M-MuLV carrying the v-src gene of Rous sarcoma virus (16) . This virus, M-MuLV(src), induced sarcomas in newborn mice, and no other neoplastic diseases were observed, indicating that the nature of the v-src oncogene was the dominant determinant in disease specificity for the virus.
In the experiments reported here, an M-MuLV carrying the v-myc oncogene from avian MC29 virus was developed. In chickens, MC29 predominantly transforms cells of the myeloid lineage. The myeloid transformation is rather specific to more differentiated myeloid cells-myelocytes, which are immediate precursors to terminally differentiated macrophages. Several other avian retroviruses carrying transduced myc also exist (e.g., CMII, MH2, and OK10), and different isolates induce carcinomas or myeloid tumors. In contrast, the cellular c-myc oncogene has been associated with several lymphoid tumors. In avian leukosis virusinduced B lymphomas the c-myc gene is activated by insertion of the avian leukosis provirus at an adjacent location (23) . A similar mechanism may be important in the development of some MuLV-induced leukemias as well (5, 20, 45) . In addition, some nonretroviral B-lymphoid leukemias in mice and humans (e.g., Burkitt's lymphoma and murine plasmacytomas) show activation of c-myc by chromosomal translocation into an actively transcribed immunoglobulin locus (12) . Thus, generation of an M-MuLV carrying the v-myc oncogene is of considerable interest. The generation and characterization of such a virus is reported here.
MATERIALS AND METHODS
Cell culture. The cell lines used in these experiments were as follows: mouse NIH 3T3 fibroblasts (52) ; A9, an NIH 3T3 clone productively infected with M-MuLV (15) ; rat XC cells (26) . All cell lines were grown in Dulbecco modified Eagle medium (GIBCO Laboratories) supplemented with 10% calf serum. Mouse embryo cultures were prepared with 14-to 19-day-old embryos from BALB/c mice. After removal of heads, appendages, and red organs, tissue was finely minced and treated with 0.05% trypsin (Irvine Scientific) in TD (0.14 M NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 25 mM Sigma 7-9), pH 7.5, at 37°C to obtain a single cell suspension. Cells were plated at 2 x 106 cells per 9-cm (diameter) dish. While still subconfluent, cells were prepared for freezing and stored in liquid nitrogen (17) . Mouse embryo cells were thawed and subpassaged twice prior to use in infections. Mouse embryo cells were grown in Dulbecco modified Eagle medium plus 10% fetal calf serum.
Recombinant DNA cloning. Starting materials used in the construction of pM-MuLV(myc) were (i) p63-2, a pBR322 derivative which contains an M-MuLV proviral clone (31) , and (ii) the 2.9-kilobase (kb) BamHI fragment including v-myc sequences of MC29 also cloned into pBR322 (43) , kindly provided by Premkumar Reddy. The v-myc containing clone was grown in the Escherichia coli GM119 (dcmdam-) in the presence of ampicillin to obtain unmethylated DNA. (BcII sites are methylated in wild-type E. coli.) The molecular cloning techniques used generally followed standard protocols (33) . DNA transfections. DNA was transfected into tissue culture cells as described previously (14, 28) . Briefly, 10 ,ug each of pM-MuLV(myc) and pSHL72 DNAs were cotransfected together with S ,Lg of calf thymus DNA into 106 NIH 3T3 cells by calcium phosphate precipitation (19) . (pSHL72 confers kanamycin resistance to mammalian cells [4] .) Approximately 4 h later, plates were treated with 25% dimethyl sulfoxide in phosphate-buffered saline and then refed with growth medium. On the following day, cultures were passaged 1:5 with medium containing the antibiotic G418 (GIBCO). G418-resistant colonies, as well as individual transformed foci resulting from infection with helper virus, were isolated by one or more cycles of selective trypsinization in cloning cylinders and grown as individual cultures (16 DNA analysis. DNA was transferred from agarose gels to nylon membranes by capillary blotting as directed by the manufacturer (New England Nuclear). Blots were prehybridized in 50% formamide-1 M NaCI-10% dextran sulfate-1% SDS at 42°C for 6 h. Labeled probe plus denatured salmon sperm DNA was then added, and hybridization was overnight at the same temperature. Washing of blots and autoradiography were as for RNA dot blots.
Labeling of cell proteins and immunoprecipitation. Subconfluent cultures were incubated at 37°C for 1 h in phosphate-free medium plus 2% calf serum. Cells were then labeled for 1 h at 37°C with 32p; (Amersham Radiochemicals) in phosphate-free medium. Proteins were extracted, immunoprecipitated, and analyzed by SDS-polyacrylamide gel electrophoresis on 10% gels as described previously (16, 21) . The antibodies used were rabbit anti-M-MuLV p30 (37) or rabbit antibody to a synthetic v-myc C-terminal peptide (kindly provided by Robert Eisenman).
Agar assays. A bottom layer of 5 ml of Dulbecco modified Eagle medium-10% calf serum containing 0.5% Bacto-Agar (32) was poured into 5-cm dishes followed by overlay with 4 ml of medium containing 0.4% Bacto-Agar and 1 x 104 to 2 x 104 cells. The cultures were then incubated for 2 weeks.
They were fed with 2 ml of 0.4% Bacto-Agar medium after 1 week. Colonies were counted at 14 days.
Titration of viral stocks. Infectivity of viral stocks was measured by titration by the XC plaque assay (44) as described previously (15) . For titration of transforming virus, NIH 3T3 cells were infected with serial dilutions of M-MuLV(myc) viral stock. Foci of transformed cells were counted 12 to 16 days postinfection.
Inoculation of mice and pathology. Neonatal NIH Swiss mice 1 to 2 days old were inoculated intraperitoneally with 0.2 ml of viral stock. Moribund animals were killed, and tissue specimens were prepared for pathological analysis as described previously (38) . (37) or rabbit anti-v-myc serum followed by collection of immunoprecipitates with fixed Staphylococcus aureus. Immunoprecipitated protein was released from the fixed bacteria and analyzed by SDS-polyacrylamide gel electrophoresis in a 10% gel (27) molecular mass of 97 kDa, whereas gPr8gOag fused to v-myc would be 112 kDa. However, when NP4-6 cells were treated with tunicamycin (which inhibits glycosylation) prior to labeling, the molecular mass of the 110-kDa NP4-6 protein did not change (lane F). This suggests that the gag-myc protein was not glycosylated and represented a fusion of Pr65zag and v-myc. The apparent discrepancy in molecular mass may reflect properties of the v-myc protein (1, 21).
RESULTS

Construction of pM-MuLV(myc
The organization of pM-MuLV(myc) preserved the MMuLV env coding sequences, as well as the splice donor and acceptor sites for spliced env mRNA. Thus, it was possible that NP4-6 cells also encoded M-MuLV env protein. To recover infectious M-MuLV(myc), NP4-6 cells were infected with replication-competent wild-type M-MuLV. Infection was feasible, since the NP4-6 cells were XC negative (env-positive cells would be resistant to M-MuLV infection).
Whereas the NP4-6 cultures resembled the parental NIH 3T3 cells morphologically, the M-MuLV-infected cells developed foci of transformed cells which overgrew the monolayer (Fig. 3) . The transformed cells tended to round up off the dish and form dense clusters of refractile cells. Foci of transformed cells were enriched by selective trypsinization in cloning rings, and one such culture was designated 46M5; a single cell clone of 46M5 was designated M5B2. The transformed 46M5 cells also produced virus [M-MuLV(myc)] which could transform uninfected NIH 3T3 cells (Fig. 3D) .
The titers of tissue culture supernatants from the 46M5 The M-MuLV(myc)-transformed cells were also tested for another property of transformed cells, growth in agar suspension. The transformed 46M5 and subcloned M5B2 cells both showed high-efficiency growth in agar (Table 1) . In contrast, nontransformed NP4-6, parental NIH 3T3, and M-MuLV-infected NIH 3T3 cells showed no growth in agar.
The appearance of transformed foci on M-MuLV-infected NP4-6 cells was surprising since the NP4-6 cells themselves contained and expressed myc RNA and protein. Subsequent analysis by Southern blot hybridization revealed that the NP4-6 cells contained an incomplete copy of M-MuLV(myc) DNA. This incomplete provirus lacked extreme 3' sequences, including the entire 3' LTR, but all of the 5' sequences, including the M-MuLV gag and MC29 gag and v-myc sequences, were intact. During infection with wildtype M-MuLV, recovery of the 3' LTR of M-MuLV(myc) presumably occurred by recombination with the infecting M-MuLV. Subsequent cycles of infection with the complete M-MuLV(myc) might produce higher levels of viral expression and result in transformation of the infected cell. Restoration of 3' MuLV LTRs to defective proviruses during infection with replication-competent MuLV has been documented by Goldfarb and Weinberg (18) . Indeed, Southern blot analysis of cells transformed with the infectious MMuLV(myc) derived from 46M5 cells confirmed the restoration of the 3' LTR (see below). VOL. 60, 1986 After discovery of the incomplete M-MuLV(myc) provirus in NP4-6 cells, other colonies of pM-MuLV(myc) DNAcontaining cells were isolated, and several which contained a complete copy of pM-MuLV(myc) DNA were identified. As expected, several of these colonies themselves showed transformed phenotypes (morphological transformation, growth in agar, or both ( Identification of M-MuLV(myc)-transformed myeloid cells. The transformed refractile cells in the M-MuLV(myc)-infected mouse embryo cultures were identified as relatively mature macrophages by a number of criteria. Phase-contrast microscopy of the infected cultures indicated that the colonies also contained nonrefractile adherent cells with the morphology typical of macrophages (Fig. 4E) . Cytocentrifugation and staining of the nonadherent cells revealed appearance typical of mature macrophages, although there were some features indicative of immaturity (nucleoli and pseudopods [ Fig. 4F] ). In addition, both adherent and nonadherent refractile cells exhibited phagocytosis of India ink particles (50) . Finally, the majority of the cells showed positive staining with Mac-1 and also with Mac-2 monoclonal antibodies as measured by flow cytometry (47) .
It was important to establish that the transformed myeloid cells were infected with M-MuLV(myc). A myeloid cell line derived from the M-MuLV(myc)-infected cultures (MAC 7) (see below), as well as the entire M-MuLV(myc)-infected mouse embryo culture (1-10), was analyzed for the presence of myc RNA by RNA dot blot analysis, and they contained relatively high levels of myc-specific RNA (Fig. 5) . The cells were also analyzed for presence of M-MuLV gag-myc fusion protein, and they showed the 110-kDa gag-myc protein found in the original NP4-6 and transformed 46M5 cells (Fig.   6 ).
M-MuLV(myc)-infected embryo cultures were also analyzed for M-MuLV(myc) proviral DNA by Southern blot hybridization (Fig. 7) were depleted of refractile cells, many of which were nonadherent or loosely adherent. This was accomplished by gentle washing and aspiration of the infected culture with a stream of growth medium. Cultures treated in this fashion repeatedly regenerated the refractile macrophages, which eventually again reached saturation density. Microscopic counting of myeloid cells from a repeatedly depleted culture indicated that in one infected culture they underwent at least 65 doublings from the initially infected cells.
Growth factor requirements of myeloid cells. For these studies, loosely adherent and nonadherent myeloid cells were removed from an infected culture as described above and tested for growth under several conditions. Culture of harvested myeloid cells in fresh growth medium resulted in complete lysis or cell death within 3 to 4 days. Thus, other factors were necessary for survival or growth. Harvested myeloid cells could also be cultured without a feeder layer but in medium conditioned by secondary mouse embryo, NIH 3T3, or MEF-1 cells. The cells demonstrated proliferative capacity, although at a somewhat reduced level in comparison with growth on feeder layers (Fig. 8D) .
The ability to transfer and grow loosely adherent and nonadherent myeloid cells allowed more detailed examination of their properties and behavior. First, when loosely adherent and nonadherent transformed myeloid cells were added to a feeder layer of an irradiated mouse embryo culture, a portion of them rapidly became adherent (arrows in Fig. 8A and B) . This confirms that the adherent macrophagelike cells associated with the original myeloid colonies were related to the nonadherent cells. Second, behavior of transformed myeloid cells harvested from MMuLV(myc)-infected cultures could be compared with normal myeloid cells harvested from control cultures. Most M-MuLV(myc)-transformed myeloid cells remained refractile and loosely adherent when harvested and cultured in conditioned medium (Fig. 8D) . In contrast, normal myeloid cells in the same medium adhered strongly to the tissue culture plastic and became less refractile (Fig. 8E) . ary mouse embryo cultures. Figures 8A, B , and C depict growth on a feeder layer, indicating that mouse embryo cultures can supply the necessary factors. Since secondary mouse embryo cultures contain cell types other than the predominant fibroblasts (e.g., the myeloid cells detected by M-MuLV(myc) transformation), it was possible that one of the minority cell populations supplied the growth factors. However, the myeloid cells could also be grown on NIH 3T3 fibroblast feeder layers or on a line of spontaneously immortalized mouse embryo fibroblasts (MEF-1). Experiments were performed to distinguish these two possibilities. First, the proliferative capacities of completely nonadherent cells from MMuLV(myc)-infected cultures were studied. These cells could be obtained by gentle aspiration of infected cultures without washing to remove loosely adherent cells, and they exhibited a uniform morphology of mature macrophages (Fig. 9A) . Nonadherent macrophages showed no proliferative capacity ( Table 2 ). The cells which passed through the Nitex morphologically resembled mature macrophages (Fig. 9B) , whereas cells retained on the Nitex consisted of some mature macrophages but additionally blastlike hematopoietic cells with high nucleus-cytoplasm ratios (Fig. 9C) .
Although the M-MuLV(myc)-transformed myeloid cells were growth factor dependent, it was possible to derive a permanent line of factor-independent myeloid cells from the infected cultures. Loosely adherent plus nonadherent cells were maintained at high cell density in conditioned medium (approximately 2 x 106 cells per 5-cm dish) and refed biweekly. After several weeks, the cultures were fed with unconditioned medium. Although cell number initially dropped after change to unconditioned medium, the number of cells in the culture gradually increased owing to outgrowth of factor-independent cells. The resulting cell line, MAC7, was passaged 1:2 in standard growth medium with fetal calf serum more than 30 times and could achieve high saturation density (Fig. 9D) . The morphology of MAC7 cells is similar to that of normal macrophages ( Fig. 9E and F, respectively ).
Molecular analyses confirmed that MAC7 cells were infected with M-MuLV(myc) and that they expressed the appropriate M-MuLV(myc)-specific RNA and protein ( Fig. 5 and 6 ). Presumably a secondary event occurred in the original factor-dependent cells to confer independence.
Immortalization and transformation of fibroblasts. The results described above indicated that M-MuLV(myc) could transform both permanent and primary fibroblasts. MMuLV(myc) was also tested for the capacity to immortalize primary mouse embryo fibroblasts. The assay was to score for colony formation after seeding of cells at low density (41) (Table 3) . In contrast to primary rat embryo fibroblasts, which show negligible levels of spontaneous immortalization, mouse embryo fibroblasts showed a measurable level of spontaneous immortalization (3 x 10-4 to 6 x 10-4). Infection with M-MuLV alone actually reduced the immortalization frequency somewhat, perhaps owing to a mild cytopathic effect. Infection with M-MuLV(myc)-M-MuLV resulted in increased immortalization-twofold in comparison with uninfected cells and threefold in comparison with M-MuLV-infected cells. There might be some concern that the M-MuLV(myc)-infected cultures only showed two to three times as many colonies as control cultures. However, this was more a reflection of the spontaneous immortalization of mouse embryo fibroblasts than the immortalization potential of M-MuLV(myc). Rassoulzadegan et al. (41) reported similar frequencies of colony formation for polyomavirus large-T antigen in rat embryo fibroblasts, although the magnitude of the effect appeared greater owing to the negligible frequency of spontaneous colony formation in control cultures.
Cytoplasmic RNA from individual immortalized colonies from the M-MuLV(myc)-infected culture was also analyzed by RNA dot blot analysis with v-myc probe (Fig. 5) . Of 10 clones analyzed, 5 contained elevated levels of myc RNA, These results are consistent with those in Table 3 . and highly refractile and lacked the stress fibers present in immortalized fibroblasts from control cultures ( Fig. 4G and  H) . In addition, M-MuLV(myc)-transformed cells appeared to be highly motile since they grew in a dispersed pattern. In fact, by 6 weeks cells in M-MuLV(myc)-infected cultures were evenly dispersed, whereas in control cultures discrete colonies of nontransformed cells were evident. Thus, MMuLV(myc) could apparently both immortalize and transform embryo fibroblasts. To investigate the pathogenicity of M-MuLV(myc) further, a stock carried by a nonpathogenic amphotropic MuLV(Am-MuLV) helper (strain 4070) was generated. It was necessary to start with a virus which would not recombine with the Am-MuLV to produce pathogenic M-MuLV. To achieve this, the M-MuLV env sequences were deleted from pM-MuLV(myc); infectious transforming virus, MMuLV(myc)'-Am-MuLV, was recovered by infection of expressing cells with Am-MuLV as described above. Although relatively low-titered stocks of M-MuLV(myc)'-AmMuLV were obtained, they were inoculated into newborn NIH Swiss mice (approximately 10 FFU per animal). Inoculated animals developed lymphoblastic leukemias at high frequency (10 of 18 in the first 6 months) with latencies between 6 and 24 weeks (mean time, 16 within the first 6 months, as expected. High-molecularweight DNA from two representative tumors was examined by Southern blot hybridization (Fig. 10) . Hybridization with a v-myc DNA probe confirmed that both of the animals contained M-MuLV(myc) proviral DNA in the tumors (Fig.  10A) . The fibroblast transformation ability of M-MuLV(myc) was interesting since others have suggested that MC29 v-myc protein may immortalize but not morphologically transform fibroblasts (29 Although the M-MuLV(myc)-transformed myeloid cells had reduced growth factor requirements, they were still factor dependent. The factors could be supplied (as conditioned medium or by cocultivation) by uninfected mouse embryo cultures or permanent fibroblast lines (36, 48) . The exact nature of the required growth factor(s) was not investigated in detail. Other investigators have identified a variety of factors involved in growth and differentiation of myeloid precursor cells (7, 35) , and it will be interesting to test defined growth factors for their effects on transformed myeloid cells.
Since the transformed myeloid cells were detected in mouse embryo cultures (which actually predominantly contained fibroblasts), it was formally possible that MMuLV(myc) infection and transformation of another cell type played a primary or secondary role in developmept of the transformed myeloid cells. For instance, if MMuLV(myc) induced mouse embryo cells to produce higher amounts or new kinds of myeloid growth factors (see, e.g., Leutz et al. [30] ), myeloid proliferation could be a secondary event. However, growth of transformed myeloid cells on irradiated feeder layers of M-MuLV(myc)-infected mouse embryo cultures depleted of myeloid cells or in conditioned medium from these cultures was not significantly different than when feeder layers or medium from uninfected mouse embryo cultures were used. The transformed properties of the M-MuLV(myc)-infected myeloid cells, as well as the fact that they were actually infected with M-MuLV(myc), also strongly support the view that M-MuLV(myc) infection of the myeloid cells themselves was the primary event. Mature, nonadherent macrophages had no capacity to divide (Table 2) . Rather, loosely adherent cells were enriched for division capacity, and in fact the bulk of the proliferative myeloid cells may actually have been tightly adherent. The loosely adherent cells of Table 2 only showed limited proliferative capacity, yet infected cultures passaged by trypsinization showed unlimited myeloid proliferative potential. Also, when M-MuLV(myc)-infected mouse embryo cultures were depleted of nonadherent and loosely adherent cells they exhibited myeloid proliferative capacity identical to that of nondepleted cultures.
Whereas the initially transformed myeloid cells were factor dependent, it was possible to derive a factorindependent macrophage line, MAC7, from them. Presumably a secondary event occurred in the transformed myeloid cells to allow growth in unconditioned medium. This might reflect loss of growth factor requirement or production of autocrine growth factors. In this regard, M-MuLV(myc) infection of an interleukin 3-dependent myeloid cell line induced interleukin 3 independence (40) . M-MuLV(myc) might also provide a useful means for generating both factor-dependent and factor-independent myeloid cells for other studies.
Whereas these experiments demonstrated the myeloid transforming capacity of M-MuLV(myc), they did not rule out transformation potential for other hematopoietic lineages. The myeloid transformation was fortuitously observed during infection of mouse embryo cultures. No particular measures were taken to favor hematopoietic cell growth. Thus, it is possible that hematopoetic target cells for other lineages (e.g., erythroid and lymphoid) were no longer present in secondary mouse embryo cultures. Additionally, if M-MuLV(myc)-transformed erythroid or lymphoid cells still required factors which could not be supplied by infected mouse embryo cultures, the culture conditions may not have supported their growth. Futher tests for hematopoietic progenitor proliferation are in progress.
In light of the myeloid and fibroblast transformation ob- 
